Clinical trial Recruiting at 1 site Observational Ages Any age to 80

Cohort study on biliary dilatation in China

Official title: Establishment and Evaluation of Clinical Classification and Surgical Decision-making System for Biliary Dilatation:a National Special Disease Cohort Study in China

Run by Beijing Tsinghua Chang Gung Hospital · NCT06881004 · Data updated 2026-11-12

This study is trying to gather information from patients with bile duct dilatation across China to better understand the condition, its risks, and the best timing for surgery.

Quick facts

Study typeObservational
AgesAny age to 80 Years
SexAll
Enrollment6000 (estimated)
SponsorBeijing Tsinghua Chang Gung Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedMarch 19, 2025
Main results expectedMarch 31, 2035
Study endsMarch 31, 2035
Registry record updatedJune 23, 2026
Trial IDNCT06881004 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients aged 0 to 80 years who have been definitively diagnosed with biliary dilation.

Probably not a fit

Patients with conditions unrelated to biliary dilation or those outside the specified age range may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter cohort study aims to continuously enroll patients with biliary dilatation from 25 medical centers across China. It will collect comprehensive data on demographics, clinical characteristics, and long-term outcomes to establish a national cohort for bile duct dilatation. The study seeks to clarify the epidemiological and pathological features of the condition, assess cancer risks, and determine optimal surgical intervention timing. Additionally, it will compare perioperative risks and quality of life among different patient types following surgical treatment.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical strategies and better long-term outcomes for patients with biliary dilatation.

How similar studies have gone: While similar cohort studies have been conducted, this specific approach to establishing a national cohort for biliary dilatation in China is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients who have been definitive diagnosed with biliary dilation.
2. Patients aged between 0 and 80 years old, regardless of gender.
3. In line with the principle of informed consent: For the retrospective cohort of biliary dilation, exemption from signing the informed consent form is applied for, while for the prospective cohort, signing the informed consent form is required.

Exclusion Criteria:

* None

Where it's running

  • Beijing Tsinghua Chang Gung Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Shuo Jin, PhD — Beijing Tsinghua Chang Gung Hospital
  • Study coordinator: Changzhen Yang, MD
  • Email: 809262038@qq.com
  • Phone: +8618810915262

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.